Martek Biosciences Settles Securities Case For $6M
A judge will consider in April whether to give final approval to a proposed $6 million settlement of a class action alleging that Martek Biosciences Corp. violated securities laws and misled...To view the full article, register now.
Already a subscriber? Click here to view full article